Corcept Therapeutics (HTD) Q1 2026 Earnings Report
CH:HTD Q1 2026 EPS Results
- Actual EPS
- -CHF 0.25
- Consensus EPS
- -CHF 0.09
- Beat/Miss
- Missed by -CHF 0.16
- One Year Ago EPS
- CHF 0.14
CH:HTD Q1 2026 Revenue Results
- Actual Revenue
- CHF 135.18M
- Expected Revenue
- CHF 151.87M
- Beat/Miss
- Missed by -CHF 16.69M
- YoY Revenue Growth
- +4.89%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/30/2026
- Time
- After Close
- Conference Call
- Thursday, April 30, 2026
CH:HTD Upcoming Earnings
Corcept Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
CH:HTD Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:HTD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | ―- | 0.16 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.65- | 0.13 | ― | |
| Jul 29, 2026 | 2026 (Q2) | 0.020.30 | 0.24 | 24.14% (+0.06) | |
| Apr 30, 2026 | 2026 (Q1) | -0.09-0.25 | 0.14 | -276.47% (-0.39) | |
| Feb 24, 2026 | 2025 (Q4) | 0.270.16 | 0.21 | -23.08% (-0.05) | |
| Nov 04, 2025 | 2025 (Q3) | 0.130.13 | 0.34 | -60.98% (-0.20) | |
| Jul 31, 2025 | 2025 (Q2) | 0.150.24 | 0.26 | -9.38% (-0.02) | |
| May 05, 2025 | 2025 (Q1) | 0.120.14 | 0.2 | -32.00% (-0.07) | |
| Feb 26, 2025 | 2024 (Q4) | 0.350.21 | 0.23 | -7.14% (-0.02) | |
| Oct 30, 2024 | 2024 (Q3) | 0.230.34 | 0.23 | 46.43% (+0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
